Clever Leaves to wind down Portugal operations
The restructuring initiative is expected to save the company USD$7 million by the end of 2023.
The restructuring initiative is expected to save the company USD$7 million by the end of 2023.
The site will be opened by UK cannabis company Eden Pharma.
Glass Pharms has announced a number of partners for its cannabis cultivation facility project.
The Arizona state University study found high levels of contaminants in cannabis products.
Akanada has signed an exclusive licensing agreement with the iconic US brand.
The licence will enable the company to manufacture finished dosage forms, dried flowers and APIs.
This is the company’s most important strategic move to date, according to CEO Avinoam Sapir
The suggestion was made during a debate on the legalisation of cannabis.
Israel-based Xinteza has unveiled it has developed a non-Cannabaceae source for cannabinoid biosynthesis in research led by professor Asaph Aharoni at the Weizmann Institute of Science USA.